(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride | |
---|---|
Trade Name | |
Orphan Indication | Hairy cell leukemia |
USA Market Approval | USA |
USA Designation Date | 2004-08-10 00:00:00 |
Sponsor | Mundipharma Research Ltd.;Cambridge Science Park, Cambridge CB4 0GW; |